Skip to content
Wenlo
Sign in
← Markets

Praxis Precision Medicines, Inc.

Marcio Souza (Chief Executive Officer) reports PRAX insider transactions

4PRAXFiled Jul 8, 2026, 12:56 PM ET· Period Jul 8, 2026

About this filing

Praxis Precision Medicines, Inc. (PRAX) filed Form 4 (insider transaction) with the SEC on Jul 8, 2026. Form 4 reports a company insider’s trades in the company’s shares.

Key facts

Insider
Marcio Souza · Chief Executive Officer, Director
DateTransactionSharesPriceValueHeld afterOwnership
Jul 8, 2026G · giftFootnotes F1−20,521$0.00$0.0056,495Direct
Jul 8, 2026G · giftFootnotes F1−2,600$0.00$0.000Indirect (Held by spouse)
Footnotes
  1. F1 This transaction represents a bona fide gift of common stock to the Souza 2026 Trust.

More PRAX filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.